Melinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018

NEW HAVEN, Conn. , July 11, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced it intends to release its second quarter 2018 financial

READ FULL TEXT

Leave a Reply

Your email address will not be published.